Surrey researchers Sign in
Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment
Journal article   Peer reviewed

Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment

PV Carroll, M Umpleby, EL Alexander, VA Egel, KV Callison, PH Sonksen and DL Russell-Jones
CLINICAL ENDOCRINOLOGY, Vol.49(6), pp.739-746
01/12/1998

Abstract

Science & Technology Life Sciences & Biomedicine Endocrinology & Metabolism ENDOCRINOLOGY & METABOLISM SUBCUTANEOUS INSULIN HEALTHY-ADULTS ADOLESCENTS SECRETION REQUIREMENTS EXPRESSION YOUNG
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000077607200007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

Details

Usage Policy